Tumor metastasis inhibition has been described upon specific genetic deletion of Tgfbr2 in myeloid cells (30) suggesting the role of myeloid-produced TGF-β in cancer progression and possibly explaining the reduced tumor numbers in Nod2ΔLyzM mice. This evidence concerns the gene TGFBR2 and neoplasm.